KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Ichor Holdings (ICHR) Research & Development (2016 - 2026)

Ichor Holdings has reported Research & Development over the past 11 years, most recently at $5.5 million for Q1 2026.

  • Quarterly Research & Development fell 5.86% to $5.5 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $22.7 million through Mar 2026, down 3.32% year-over-year, with the annual reading at $23.1 million for FY2025, 0.3% changed from the prior year.
  • Research & Development was $5.5 million for Q1 2026 at Ichor Holdings, down from $5.6 million in the prior quarter.
  • Over five years, Research & Development peaked at $5.9 million in Q2 2024 and troughed at $4.3 million in Q1 2023.
  • The 5-year median for Research & Development is $5.5 million (2026), against an average of $5.4 million.
  • Year-over-year, Research & Development surged 38.01% in 2022 and then dropped 11.09% in 2023.
  • A 5-year view of Research & Development shows it stood at $4.9 million in 2022, then grew by 11.87% to $5.5 million in 2023, then rose by 5.71% to $5.8 million in 2024, then fell by 4.21% to $5.6 million in 2025, then decreased by 1.32% to $5.5 million in 2026.
  • Per Business Quant, the three most recent readings for ICHR's Research & Development are $5.5 million (Q1 2026), $5.6 million (Q4 2025), and $5.9 million (Q3 2025).